First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 3.9% of the 50,761 shares held after it.
No other insider sold within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Chief Operations Officer BASSETT JOHN E III sold about $37.1K of BSET on Jul 23, 2025, the largest insider sale at the company on our record; 30 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 13, 2024.
+19.8% median (+17.2% mean) 90-day return after 3 previous buys.
The trade is 0.3% of the 263,000 shares held after it.
2 other insiders bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman & CEO SPILMAN ROBERT H JR bought about $9.3K of BSET on Aug 14, 2024; 2 other insiders bought within 30 days and 30 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Apr 28, 2023.
+15.9% median (+15.9% mean) 90-day return after 2 previous buys.
The trade is 0.4% of the 262,277 shares held after it.
2 other insiders bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman & CEO SPILMAN ROBERT H JR bought about $12.4K of BSET on Aug 13, 2024; 2 other insiders bought within 30 days and 30 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 9.4% of the 41,047 shares held after it.
2 other insiders bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BELK JOHN R bought about $48.9K of BSET on Aug 12, 2024, the largest insider purchase at the company since 2022; 2 other insiders bought within 30 days and 30 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Apr 25, 2023.
The trade is 0.9% of the 53,422 shares held after it.
2 other insiders bought within 30 days.
30 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Chief Fin./Admin. Officer Daniel John Michael bought about $6.4K of BSET on Aug 7, 2024; 2 other insiders bought within 30 days and 30 funds added in the latest 13F quarter.
12 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BSET planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
BSET mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Aegis Value Fund
$9.4M position · as of 2026-06-30
0.8%
Gabelli Global Mini Mites Fund
$97.5K position · as of 2026-06-30
0.4%
Columbia Small Cap Value Discovery Fund
$4.9M position · as of 2026-07-31
0.2%
1290 GAMCO Small/Mid Cap Value Fund
$455.3K position · as of 2026-07-31
0.2%
Columbia Variable Portfolio - Small Cap Value Discovery Fund
$731.8K position · as of 2026-06-30
0.2%
1290 VT GAMCO Small Company Value Portfolio
$7.0M position · as of 2026-06-30
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Spilman
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$826.5K
$827.8K
$520.5K
+7%
n/a
2024
$491.9K
$485.6K
$344.2K
+12%
n/a
2023
$533.8K
$526.5K
$361.1K
+16%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 30 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$335.6M
four quarters, 2025-08-31 to 2026-08-29
Revenue, TTM BSET
FY Nov 2025
$335.3M
FY Nov 2024
n/a
FY Nov 2023
$390.1M
FY Nov 2022
$485.6M
FY Nov 2021
$486.5M
Aug 2026
$82.8M
May 2026
$83.8M
Feb 2026
$80.3M
Nov 2025
$88.7M
Aug 2025
$80.1M
May 2025
$84.3M
Mar 2025
$82.2M
Nov 2024
$84.3M
At each fiscal year end
Single quarter
Net margin, TTM
+2.0%
net income over revenue, 2025-08-31 to 2026-08-29
Net margin, TTM BSET
FY Nov 2025
+1.8%
FY Nov 2024
n/a
FY Nov 2023
-0.8%
FY Nov 2022
+13.5%
FY Nov 2021
+3.7%
Aug 2026
+2.5%
May 2026
+2.4%
Feb 2026
+1.4%
Nov 2025
+1.7%
Aug 2025
+1.0%
May 2025
+2.3%
Mar 2025
+2.3%
Nov 2024
+3.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$8.1M
operating cash flow minus capex, 2025-08-31 to 2026-08-29
Free cash flow, TTM BSET
FY Nov 2025
$9.0M
FY Nov 2024
-$1.2M
FY Nov 2023
$1.2M
FY Nov 2022
-$24.3M
FY Nov 2021
$3.8M
Aug 2026
$1.8M
May 2026
$5.6M
Feb 2026
-$6.3M
Nov 2025
$7.0M
Aug 2025
-$2.6M
May 2025
$5.6M
Mar 2025
-$923.0K
Nov 2024
$5.9M
At each fiscal year end
Single quarter
Debt to equity
0.00x
LongTermDebt as filed 2018-11-24 (94 months older than the period end) (includes the current portion); equity 2026-08-29
Debt to equity BSET
FY Nov 2025
0.00x
FY Nov 2024
0.00x
FY Nov 2023
0.00x
FY Nov 2022
0.00x
FY Nov 2021
0.00x
Aug 2026
0.00x
May 2026
0.00x
Feb 2026
0.00x
Nov 2025
0.00x
Aug 2025
0.00x
May 2025
0.00x
Mar 2025
0.00x
Nov 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
54.03x
TTM operating cash flow over LongTermDebt as filed 2018-11-24 (94 months older than the period end) (includes the current portion)
Cash flow to debt BSET
FY Nov 2025
46.20x
FY Nov 2024
13.87x
FY Nov 2023
64.12x
FY Nov 2022
-10.17x
FY Nov 2021
49.87x
Aug 2026
54.03x
May 2026
29.05x
Feb 2026
27.65x
Nov 2025
46.20x
Aug 2025
41.43x
May 2025
44.08x
Mar 2025
40.20x
Nov 2024
13.87x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.1%
TTM net income over average of 2025-08-30 and 2026-08-29
Return on equity BSET
FY Nov 2025
+3.7%
FY Nov 2024
n/a
FY Nov 2023
-1.7%
FY Nov 2022
+36.5%
FY Nov 2021
+11.2%
Aug 2026
+4.1%
May 2026
+3.3%
Feb 2026
+3.2%
Nov 2025
+3.7%
Aug 2025
+4.7%
May 2025
+1.5%
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.1%
TTM net income over average of 2025-08-30 and 2026-08-29
Return on assets BSET
FY Nov 2025
+1.8%
FY Nov 2024
n/a
FY Nov 2023
-0.8%
FY Nov 2022
+15.8%
FY Nov 2021
+4.4%
Aug 2026
+2.1%
May 2026
+1.7%
Feb 2026
+1.6%
Nov 2025
+1.8%
Aug 2025
+2.4%
May 2025
+0.7%
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+4.5%
operating income after a 30.0% effective tax rate, over LongTermDebt as filed 2018-11-24 (94 months older than the period end) (includes the current portion) plus average of 2025-08-30 and 2026-08-29 minus cash
Return on invested capital BSET
FY Nov 2025
+4.3%
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
+19.7%
FY Nov 2021
n/a
Aug 2026
+4.5%
May 2026
+3.4%
Feb 2026
+3.5%
Nov 2025
+4.3%
Aug 2025
n/a
May 2025
n/a
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+3.4%
operating income (EBIT proxy) over average of 2025-08-30 and 2026-08-29 minus current liabilities
Return on capital employed BSET
FY Nov 2025
+3.0%
FY Nov 2024
n/a
FY Nov 2023
-1.0%
FY Nov 2022
+11.8%
FY Nov 2021
n/a
Aug 2026
+3.4%
May 2026
+2.5%
Feb 2026
+2.6%
Nov 2025
+3.0%
Aug 2025
+2.5%
May 2025
-0.2%
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
28.65x
close 2026-10-27 over four quarters of diluted EPS, 2025-08-31 to 2026-08-29
P/E, trailing BSET
FY Nov 2025
22.51x
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
n/a
FY Nov 2021
9.17x
Aug 2026
24.03x
May 2026
23.75x
Feb 2026
24.54x
Nov 2025
22.51x
Aug 2025
18.90x
May 2025
59.54x
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$158.3M
market value at close 2026-10-27 on 2026-09-24 shares, plus LongTermDebt as filed 2018-11-24 (94 months older than the period end) (includes the current portion), minus cash 2026-08-29
Enterprise value BSET
FY Nov 2025
$93.9M
FY Nov 2024
$94.8M
FY Nov 2023
$94.6M
FY Nov 2022
$109.1M
FY Nov 2021
$129.7M
Aug 2026
$127.2M
May 2026
$93.8M
Feb 2026
$96.9M
Nov 2025
$93.9M
Aug 2025
$112.0M
May 2025
$106.0M
Mar 2025
$103.1M
Nov 2024
$94.8M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.2%
TTM free cash flow over market value at close 2026-10-27
FCF yield BSET
FY Nov 2025
+6.6%
FY Nov 2024
-0.9%
FY Nov 2023
+0.8%
FY Nov 2022
-14.2%
FY Nov 2021
+2.3%
Aug 2026
+5.0%
May 2026
+2.8%
Feb 2026
+2.7%
Nov 2025
+6.6%
Aug 2025
+5.4%
May 2025
+6.3%
Mar 2025
+5.6%
Nov 2024
-0.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -12%, PEG needs growth
PEG, trailing BSET
FY Nov 2025
n/a
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
n/a
FY Nov 2021
n/a
Aug 2026
n/a
May 2026
0.19x
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Mar 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BSET ranks highest on financial health (93rd percentile) and risk and compliance (85th), and lowest on institutional and government (28th), among Consumer Goods peers.
Profitability
35
Inputs
Return on equity+4.1% · 44 pct, sector of 105
Return on assets+2.1% · 50 pct, sector of 124
Return on invested capital+4.5% · 2 pct, sector of 51
Return on capital employed+3.4% · 43 pct, sector of 108
Financial health
93
Inputs
Debt to equity0.00x · 87 pct, sector of 112
Cash flow to debt54.03x · 99 pct, sector of 96
Growth
47
Inputs
Revenue growth, YoY+1.6% · 47 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
28
Inputs
Funds adding, latest quarter30 · 28 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
85
Inputs
Short interest, % of float+0.5% · 78 pct, sector of 159
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 102
New text in Risk Factors, latest 10-K+7.4% · 78 pct, sector of 111
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.